Swiss National Bank’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-382,000
| Closed | -$1.57M | – | 2835 |
|
|
2022
Q1 | $1.57M | Buy |
382,000
+27,700
| +8% | +$100K | ﹤0.01% | 2170 |
|
|
2021
Q4 | $1.26M | Hold |
354,300
| – | – | ﹤0.01% | 2333 |
|
|
2021
Q3 | $1.29M | Buy |
354,300
+5,300
| +2% | +$21.4K | ﹤0.01% | 2311 |
|
|
2021
Q2 | $1.52M | Sell |
349,000
-12,800
| -4% | -$52.1K | ﹤0.01% | 2271 |
|
|
2021
Q1 | $1.49M | Buy |
361,800
+5,300
| +1% | +$23K | ﹤0.01% | 2172 |
|
|
2020
Q4 | $1.42M | Hold |
356,500
| – | – | ﹤0.01% | 2114 |
|
|
2020
Q3 | $963K | Buy |
356,500
+10,400
| +3% | +$28.8K | ﹤0.01% | 2108 |
|
|
2020
Q2 | $952K | Buy |
346,100
+45,400
| +15% | +$127K | ﹤0.01% | 2133 |
|
|
2020
Q1 | $710K | Buy |
300,700
+4,200
| +1% | +$14.3K | ﹤0.01% | 2006 |
|
|
2019
Q4 | $1.39M | Buy |
296,500
+6,700
| +2% | +$27.4K | ﹤0.01% | 1939 |
|
|
2019
Q3 | $969K | Buy |
289,800
+11,300
| +4% | +$37.2K | ﹤0.01% | 2075 |
|
|
2019
Q2 | $916K | Buy |
278,500
+20,100
| +8% | +$58.1K | ﹤0.01% | 2161 |
|
|
2019
Q1 | $783K | Buy |
258,400
+7,900
| +3% | +$25.6K | ﹤0.01% | 2199 |
|
|
2018
Q4 | $681K | Buy |
+250,500
| New | +$825K | ﹤0.01% | 2223 |
|
|
2015
Q4 | – | Sell |
-196,300
| Closed | -$334K | – | 2664 |
|
|
2015
Q3 | $334K | Buy |
196,300
+29,900
| +18% | +$58.6K | ﹤0.01% | 2361 |
|
|
2015
Q2 | $346K | Buy |
166,400
+21,600
| +15% | +$52.4K | ﹤0.01% | 2404 |
|
|
2015
Q1 | $392K | Hold |
144,800
| – | – | ﹤0.01% | 2296 |
|
|
2014
Q4 | $372K | Buy |
144,800
+7,500
| +5% | +$16.8K | ﹤0.01% | 2329 |
|
|
2014
Q3 | $251K | Hold |
137,300
| – | – | ﹤0.01% | 2386 |
|
|
2014
Q2 | $367K | Hold |
137,300
| – | – | ﹤0.01% | 2313 |
|
|
2014
Q1 | $481K | Buy |
137,300
+28,200
| +26% | +$125K | ﹤0.01% | 2139 |
|
|
2013
Q4 | $489K | Hold |
109,100
| – | – | ﹤0.01% | 2004 |
|
|
2013
Q3 | $443K | Sell |
109,100
-10,200
| -9% | -$44.5K | ﹤0.01% | 2005 |
|
|
2013
Q2 | $496K | Buy |
+119,300
| New | +$461K | ﹤0.01% | 1925 |
|
Other funds holding ATRS
Swiss National Bank's ATRS Position: Q2 2022 in Review
Swiss National Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 382,000 shares — an estimated $1.57M sold.
Swiss National Bank first reported a position in ATRS in Q2 2013 and held it in 24 quarters. The position peaked at $1.57M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Swiss National Bank reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Swiss National Bank sold 382,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.57M.
- Swiss National Bank first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 24 quarters.
- Swiss National Bank's Antares Pharma, Inc. position peaked at $1.57M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.